Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Filters applied: . Clear all
Page 1
Large-scale releases and establishment of wMel Wolbachia in Aedes aegypti mosquitoes throughout the Cities of Bello, Medellín and Itagüí, Colombia.
Velez ID, Uribe A, Barajas J, Uribe S, Ángel S, Suaza-Vasco JD, Mejia Torres MC, Arbeláez MP, Santacruz-Sanmartin E, Duque L, Martínez L, Posada T, Patiño AC, Gonzalez SM, Velez AL, Ramírez J, Salazar M, Gómez S, Osorio JE, Iturbe-Ormaetxe I, Dong Y, Muzzi FC, Rances E, Johnson PH, Smithyman R, Col B, Green BR, Frossard T, Brown-Kenyon J, Joubert DA, Grisales N, Ritchie SA, Denton JA, Gilles JRL, Anders KL, Kutcher SC, Ryan PA, O'Neill SL. Velez ID, et al. Among authors: johnson ph. PLoS Negl Trop Dis. 2023 Nov 30;17(11):e0011642. doi: 10.1371/journal.pntd.0011642. eCollection 2023 Nov. PLoS Negl Trop Dis. 2023. PMID: 38032856 Free PMC article.
Based on results from previous studies, we expect that Wolbachia establishment will be sustained long term. Ongoing monitoring will confirm Wolbachia persistence in local mosquito populations and track its establishment in the remaining areas....
Based on results from previous studies, we expect that Wolbachia establishment will be sustained long term. Ongoing monitoring will c …
Antibody based therapies in Hodgkin lymphoma.
Radhakrishnan VS, Longley J, Johnson PWM. Radhakrishnan VS, et al. Among authors: johnson pwm. Cancer Treat Rev. 2024 Jan;122:102647. doi: 10.1016/j.ctrv.2023.102647. Epub 2023 Oct 28. Cancer Treat Rev. 2024. PMID: 37988820 Free article. Review.
Resistance to therapy manifested by refractory and relapsed disease, and treatment related short- and long-term morbidity are the key challenges. Patient outcomes have improved in the recent past with the advent of novel therapies and are borne out of a better understandin …
Resistance to therapy manifested by refractory and relapsed disease, and treatment related short- and long-term morbidity are the key …
Characterizing the Gut Microbial Communities of Native and Invasive Freshwater Bivalves after Long-Term Sample Preservation.
Vaughn SN, Atkinson CL, Johnson PD, Jackson CR. Vaughn SN, et al. Among authors: johnson pd. Microorganisms. 2023 Oct 4;11(10):2489. doi: 10.3390/microorganisms11102489. Microorganisms. 2023. PMID: 37894147 Free PMC article.
In this study, we determine whether ethanol-stored specimens of freshwater mussels can yield representative information about their gut microbiomes such that changes in the microbiome through time could potentially be determined from museum mussel collections. A short-term …
In this study, we determine whether ethanol-stored specimens of freshwater mussels can yield representative information about their gut micr …
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.
Luminari S, Fossa A, Trotman J, Molin D, d'Amore F, Enblad G, Berkahn L, Barrington SF, Radford J, Federico M, Kirkwood AA, Johnson PWM. Luminari S, et al. Among authors: johnson pwm. J Clin Oncol. 2024 Jan 1;42(1):13-18. doi: 10.1200/JCO.23.01177. Epub 2023 Oct 26. J Clin Oncol. 2024. PMID: 37883739 Free PMC article. Clinical Trial.
Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.We analyzed long-term results of the response-adapted trial for adult patients with advanc …
Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the p …
A Rebalancing of Financial Valuations and Expectations Moving Forward in the Telehealth Sector as the United States Moves Toward a Post-COVID-19 Reality.
Bettencourt N, Wilson CJ, Johnson PJ, D'Souza F. Bettencourt N, et al. Among authors: johnson pj. J Med Internet Res. 2023 Jul 31;25:e35857. doi: 10.2196/35857. J Med Internet Res. 2023. PMID: 37523216 Free PMC article.
Furthermore, consideration of the areas of medicine and characteristics that best lend themselves to web-based care may lead to a greater chance for long-term success in a postpandemic health care delivery system. In the future, we believe investors should expect a bullish …
Furthermore, consideration of the areas of medicine and characteristics that best lend themselves to web-based care may lead to a greater ch …
Spatiotemporal quantitative microRNA-155 imaging reports immune-mediated changes in a triple-negative breast cancer model.
Skourti E, Volpe A, Lang C, Johnson P, Panagaki F, Fruhwirth GO. Skourti E, et al. Among authors: johnson p. Front Immunol. 2023 Jun 8;14:1180233. doi: 10.3389/fimmu.2023.1180233. eCollection 2023. Front Immunol. 2023. PMID: 37359535 Free PMC article.
METHODS: We developed an in vivo microRNA detector platform in which the obtained signals are positively correlated to microRNA presence, and which permitted stable expression in cancer cells as needed for long-term experimentation in tumor biology. It exploits a radionucl …
METHODS: We developed an in vivo microRNA detector platform in which the obtained signals are positively correlated to microRNA presence, an …
Retrospective Review of Directional Atherectomy and Drug-Coated Balloon Use in a PAD Safety-Net Population.
Hogan SE, Holland M, Burke J, Johnson P, McNeal D, Cicutto L, Nehler M, Peterson PN. Hogan SE, et al. Among authors: johnson p. J Invasive Cardiol. 2023 Apr;35(4):E205-E216. J Invasive Cardiol. 2023. PMID: 37029994 Free article.
OBJECTIVE: To review demographic and clinical characteristics, and short- intermediate term outcomes of patients presenting to a safety-net hospital with PAD treated with DA and DCB during LER. ...
OBJECTIVE: To review demographic and clinical characteristics, and short- intermediate term outcomes of patients presenting to a safe …
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma.
Mosconi C, O'Rourke J, Kloeckner R, Sturm L, Golfieri R, Celsa C, Fateen W, Odisio BC, Garanzini EM, Peck-Radosavljevic M, Borghi A, Ma YT, Stoehr F, Bettinger D, Giuffrida P, Aithal GP, Lin YM, Spreafico C, Giampalma E, Johnson P, Cucchetti A. Mosconi C, et al. Among authors: johnson p. Cardiovasc Intervent Radiol. 2023 Apr;46(4):449-459. doi: 10.1007/s00270-023-03375-4. Epub 2023 Feb 27. Cardiovasc Intervent Radiol. 2023. PMID: 36849836
Grade of adverse event was classified according to the Common Terminology Criteria for Adverse Events and short-term efficacy was assessed by response. Pooled estimates were calculated to account for hospital's effect and risk-adjustment was applied to allow for diversity …
Grade of adverse event was classified according to the Common Terminology Criteria for Adverse Events and short-term efficacy was ass …
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?
Cucchetti A, Elshaarawy O, Han G, Chong CCN, Serra C, O'Rourke JM, Crew R, Felicani C, Ercolani G, Shah T, Vogel A, Lai PBS, Johnson PJ. Cucchetti A, et al. Among authors: johnson pj. Br J Cancer. 2023 May;128(9):1665-1671. doi: 10.1038/s41416-023-02188-z. Epub 2023 Feb 17. Br J Cancer. 2023. PMID: 36807338 Free PMC article.
BACKGROUND: Treatment of hepatocellular carcinoma (HCC) is predicated on early diagnosis such that 'curative therapies' can be successfully applied. The term 'curative' is, however, poorly quantitated. We aimed to complement our previous work by developing a statistical mo …
BACKGROUND: Treatment of hepatocellular carcinoma (HCC) is predicated on early diagnosis such that 'curative therapies' can be successfully …
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
IMPORTANCE: Anti-vascular endothelial growth factor (VEGF) injections in eyes with nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema (CI-DME) reduce development of vision-threatening complications from diabetes over at least 2 years, but …
IMPORTANCE: Anti-vascular endothelial growth factor (VEGF) injections in eyes with nonproliferative diabetic retinopathy (NPDR) without cent …
336 results